Stock Spotlight Archives - Page 142 of 378

FridayNov 05, 2021 2:37 pm

QualityStocksNewsBreaks – Avricore Health Inc.’s (TSX.V: AVCR) (OTCQB: AVCRF) HealthTab(TM) Enabling Patients to ‘Take Direct Agency over Their Health’

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF), a diagnostics technology innovator, is taking part in the digital transformation as well as satisfying emerging consumer preferences through its flagship offering, HealthTab(TM). HealthTab is a turnkey point-of-care (“POC”) testing solution that combines a secure, cloud-based platform with best-in-class POC technologies to improve the quality of life for patients living with chronic illnesses. The platform enables consumers with convenient and timely access to important health information. A recent article reads, “This is especially critical at a time when increasingly health-conscious consumers are looking for these exact technologies and services.” “What HealthTab does is it…

ThursdayNov 04, 2021 11:26 am

QualityStocksNewsBreaks – Tingo Inc. (IWBB), MELD Partnership Bringing Financial Freedom, Individualized Control to Masses

Tingo (OTCQB: IWBB) recently announced a partnership with MELD, a DeFi non-custodial banking protocol for secure lending and borrowing of crypto and fiat currencies, in a bid to bring the protocol to customers in Africa. “Working within the framework of the United Nations’ SDGs and Environmental, Social and Corporate Governance (‘ESG’) impact investing, Tingo aims to be part of the solution for the African continent in several key areas — including food security — through the promotion of female entrepreneurship, financial inclusion, poverty alleviation and zero hunger,” reads a recent article. “With this unique partnership, Tingo hopes to make its…

ThursdayNov 04, 2021 11:10 am

QualityStocksNewsBreaks – Infobird Software Co. Ltd. (NASDAQ: IFBD) Helping Clients Increase Revenue, Reduce Costs, Enhance Customer Service

Infobird (NASDAQ: IFBD), a business-to-business (“B2B”) artificial intelligence (“AI”) solutions company, empowers clients with business-driven solutions that help increase revenue, reduce costs and enhance customer service quality and satisfaction. With over ten years of experience providing customer engagement and SaaS for large enterprises in the finance industry, IFBD has a comprehensive customer engagement SaaS solutions portfolio that is highly intelligent, customizable, provides proof of stability and security at scale, and includes a concurrence of over 10,000 agents. Recently, the company extended its dedication and commitment to improving its offering by successfully expanding into the consumer and retail product providers market.…

WednesdayNov 03, 2021 2:49 pm

QualityStocksNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) Targeting Three Primary Segments for Innovative Tech, Starting with Agriculture

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) offers an answer to hydrogen production and distribution issues through its proprietary modular and scalable carbon-free ammonia (“NH3”) technology. The company is targeting three primary segments — agriculture, transportation and energy storage — but will initially focus its demonstration programs, slated for rollout in early 2022, on agriculture where NH3 is already used as fertilizer. Farms can use FuelPositive’s technology to produce carbon-free ammonia for multiple other purposes. According to a recent article, these include “to power tractors and harvesters, to replace propane in crop-drying systems and, in general, to replace the sector’s reliance on…

TuesdayNov 02, 2021 3:17 pm

QualityStocksNewsBreaks – StraightUp Resources Inc. (CSE: ST) Making Indelible Mark on the Mining Scene

StraightUp Resources (CSE: ST) is positioning itself in the mining sector and maximizing shareholder wealth and value through its focus on strategic acquisitions and exploration work. Following the completion of an initial public offering (“IPO”) in March last year and a non-brokered private placement a month later, StraightUp embarked on a journey that saw it acquire the RLX North, RLX South and Belanger Red Lake gold properties in June 2020, the Ferdinand Gold Property in Ontario in March of this year, and the Bear Head Gold Property later in July. The company also commenced a ground magnetic (“MAG”) survey at…

TuesdayNov 02, 2021 3:06 pm

QualityStocksNewsBreaks – Excellon Resources Inc. (NYSE American: EXN) (TSX: EXN) (FSE: E4X2) Well Primed to Serve Burgeoning Precious Metals Market

Excellon Resources (NYSE American: EXN) (TSX: EXN) (FSE: E4X2), a silver and base metals producer with precious metals projects in Mexico, Idaho and Germany, has employed a world-class leadership team with a proven track record to capitalize on positive trends in the precious metals space even as the results of the market’s increasingly optimistic outlook on silver’s prospects are seen in North America, Europe and Asia. A six-story high warehouse near Singapore’s Changi airport, which currently holds around 400 tons of silver, is expected to store as much as 15,000 tons once complete, indicating the potential that the market currently…

TuesdayNov 02, 2021 2:43 pm

QualityStocksNewsBreaks – Why Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Is ‘One to Watch’

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) is a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders. Founded in 2020 based on delivering to significant unmet need in the mental health and therapeutic treatment environments, Mydecine is dedicated to efficiently developing innovative first- and second-generation novel therapeutics to treat PTSD, addiction and other disorders. “The company currently has four lead drug candidates, which include various enhancements such as improved controllability, delivery mechanisms, safety, stability and shelf-life. The drug candidates are in clinical trials or in pre-trial stage as potential treatments to aid…

TuesdayNov 02, 2021 2:33 pm

QualityStocksNewsBreaks – FingerMotion Inc. (FNGR) Targeting Development of Innovative Insurtech, Fintech Products for Customers

FingerMotion (OTCQX: FNGR) launched its youngest operational division, Sapientus, in mid-2020 following years of R&D work. “In the past few years, we’ve had our inhouse team of actuaries and data scientists, who really know the ins and outs of the insurance industry, and what they’ve been doing is they’ve been deciphering information from all these different sources and putting in the risk metrics that could provide those fresh insights and intelligence for the insurance field,” a recent article quotes FingerMotion CEO Martin Shen as saying. “FingerMotion believes that by integrating its Sapientus data blocks with external data sources such as…

MondayNov 01, 2021 12:49 pm

QualityStocksNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) on Target to Become House of Brands, Great Channel Partner

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) recently welcomed former U.S. Congressman and now public policy consultant Ryan Costello to its board of directors. Costello is expected to deepen RWB’s U.S.-based representation, which is key as federal policy on cannabis shifts. The company also announced that it has built a new production facility to good manufacturing practice (“GMP”) specifications in Florida as part of an effort to capitalize on the growing cannabis derivative market there. The Florida facility is built to accommodate the demand for edibles. “Red White & Bloom has built a branded capsule and rosin line…

MondayNov 01, 2021 11:38 am

QualityStocksNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Leading Way Through Unique Psychedelic Drug Development Focus

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) is nearing the launch of a phase 2a clinical trial that aims to establish the value of its psychedelic drug candidate, TRP-8802, in treating chronic and severe eating disorders such as Prader-Willi Syndrome (“PWS”), hypothalamic obesity disorder resulting from the removal of a brain tumor, and binge eating dysfunction. Tryp also plans to execute phase 2b clinical trials for its proprietary psychedelic candidate TRP-8803 to evaluate its ability to penetrate the natural blood-brain barrier and effectively alleviate pain and addiction concerns, including targets for phantom limb pain and fibromyalgia. “Tryp’s product development moves beyond…

Site Search

Company Search

Category: Stock Spotlight